December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Heat Shock Protein Expression in Uveal Melanoma
Author Affiliations & Notes
  • GS O A Missotten
    Ophthalmology Leiden University Medical Center Leiden Netherlands
  • ER Barthen
    Ophthalmology Leiden University Medical Center Leiden Netherlands
  • JE E Keunen
    Ophthalmology Leiden University Medical Center Leiden Netherlands
  • HM H Hurks
    Ophthalmology Leiden University Medical Center Leiden Netherlands
  • MJ Jager
    Ophthalmology Leiden University Medical Center Leiden Netherlands
  • Footnotes
    Commercial Relationships   G.S.O.A. Missotten, None; E.R. Barthen, None; J.E.E. Keunen, None; H.M.H. Hurks, None; M.J. Jager, None. Grant Identification: Dutch Cancer Foundation (KWF)
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2217. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      GS O A Missotten, ER Barthen, JE E Keunen, HM H Hurks, MJ Jager; Heat Shock Protein Expression in Uveal Melanoma . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2217.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Since heat shock proteins (hsp) are used as stimulators of tumor vaccination and their expression is of prognostic significance in several tumors, we determined the expression of heat shock proteins 27, 70, 90 and glycoprotein (gp) 96 in uveal melanoma. We also investigated whether hsp expression was associated with known prognostic parameters. Methods: Expression of hsp27, hsp70, hsp90 and gp96 was determined on formalin-fixed and paraffin-embedded sections of 20 uveal melanomas by immunohistochemistry (alkaline phosphatase anti-phosphatase staining) with specific monoclonal antibodies, and scored semi-quantitavely. Results: Expression of the different hsps on uveal melanomas was variable. We noted expression of hsp27 in all uveal melanomas with 30 to 100% (average 74%) of cells stained. Hsp70 and hsp90 were expressed in less than 10% of cells in respectively 80% and 55% of uveal melanomas. Expression of gp96 occured in 90% (0-100%, average 59% of cells) of uveal melanomas. The percentage of heat shock protein expression did not correlate significantly with known prognostic factors (largest basal tumor diameter, mitotic rate, or cell type). Conclusion: Expression of heat shock proteins is not correlated with known prognostic factors in uveal melanomas. The high expression of gp96 on 90% of uveal melanomas indicates, however, that this protein could be used as a potential trigger in tumor vaccination.

Keywords: 464 melanoma • 496 oncology • 434 immunohistochemistry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×